Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver and Intrahepatic Biliary Tract Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06690970
What this trial is testing

Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients

Who this might be right for
PSMA-related DiseaseProstate CancerPositron Emission Tomography+3 more
Tianjin Medical University 500
Large-scale testing (Phase 3)Study completedNCT00003994
What this trial is testing

Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer

Who this might be right for
Childhood HepatoblastomaRecurrent Childhood Liver CancerStage I Childhood Liver Cancer
Children's Oncology Group 277
Testing effectiveness (Phase 2)Study completedNCT00321594
What this trial is testing

Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 54
Not applicableEnded earlyNCT05184283
What this trial is testing

Utilization of MAsS in Patients Undergoing LT for HCC

Who this might be right for
NAFLDHepatocellular CarcinomaLiver Diseases+3 more
Columbia University 11
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07682454
What this trial is testing

Utilize Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial Nitroglycerin

Who this might be right for
Hepatocellular Carcinoma (HCC)Liver Cancer, Adult
University of California, San Francisco 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07363356
What this trial is testing

Drug Sensitivity Testing-Based Tumor Organoids to Guide Adjuvant Therapy After Hepatectomy for Primary Liver Cancer

Who this might be right for
Hepatocellular Carcinoma Resectable
Eastern Hepatobiliary Surgery Hospital 56
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00775073
What this trial is testing

Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001

Who this might be right for
Hepatocellular Carcinoma
Gerhard Treiber 33
Not applicableEnded earlyNCT04315883
What this trial is testing

Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors

Who this might be right for
HepatoblastomaHepatocellular CarcinomaRhabdoid Tumor of Liver+3 more
Nemours Children's Clinic 3
Not applicableLooking for participantsNCT07070362
What this trial is testing

Digital Early Warning System for Acute Lung Injury in Liver Surgery

Who this might be right for
Acute Lung Injury(ALI)Liver CirrhosisARDS, Human+4 more
Beijing Tsinghua Chang Gung Hospital 3,000
Not applicableStudy completedNCT03133286
What this trial is testing

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)

Who this might be right for
Radiation TherapyCancerCancer of Anus+16 more
DxTerity Diagnostics 16
Testing effectiveness (Phase 2)Looking for participantsNCT05690048
What this trial is testing

Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)

Who this might be right for
ImmunotherapyHCC - Hepatocellular Carcinoma
Michael Dill 48
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Not applicableLooking for participantsNCT00451022
What this trial is testing

Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies

Who this might be right for
Prostate CancerLiver CancerBreast Cancer+2 more
National Cancer Institute (NCI) 750
Not applicableUnknownNCT05242237
What this trial is testing

Prognostic Value of Liver Cancer CTCs Isolated by a Novel Microfluidic Platform

Who this might be right for
Hepatocellular CarcinomaCirculating Tumor CellWhole Genome Sequencing
The Second Affiliated Hospital of Chongqing Medical University 300
Not applicableNot Yet RecruitingNCT06994130
What this trial is testing

Seravue Validation Study for Hepatocellular Carcinoma (HCC) Diagnosis

Who this might be right for
Hepatic Cancer
ImCare Biotech 1,392
Very early researchUnknownNCT05411757
What this trial is testing

IBR900 Cell Injection Combined With Lenvatinib or Bevacizumab in the Treatment of Advanced Primary Liver Cancer

Who this might be right for
Advanced Primary Liver Cancer
Shandong Public Health Clinical Center 12
Testing effectiveness (Phase 2)Study completedNCT01334112
What this trial is testing

Study of Axitinib in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 30
Not applicableStudy completedNCT06720675
What this trial is testing

Ex-vivo Hypotermic Perfusion in Patients With Hepatocellular Carcinoma to Reduce the Incidence of Tumor Recurrence

Who this might be right for
Liver CarcinomaLiver TransplantTumor Recurrence+2 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 237
Next Page